Visekruna A - Search Results

1

Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells.

Strehl B, Joeris T, Rieger M, Visekruna A, Textoris-Taube K, Kaufmann SH, Kloetzel PM, Kuckelkorn U, Steinhoff U. Strehl B, et al. Among authors: visekruna a. J Immunol. 2006 Nov 1;177(9):6238-44. doi: 10.4049/jimmunol.177.9.6238. J Immunol. 2006. PMID: 17056553

2

The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment.

Luu M, Schütz B, Lauth M, Visekruna A. Luu M, et al. Among authors: visekruna a. Cancers (Basel). 2023 Mar 3;15(5):1588. doi: 10.3390/cancers15051588. Cancers (Basel). 2023. PMID: 36900377 Free PMC article. Review.

3

Leprosy susceptibility-a matter of protein degradation? The role of proteasomes in infection and disease.

Steinhoff U, Visekruna A. Steinhoff U, et al. Among authors: visekruna a. Int J Lepr Other Mycobact Dis. 2005 Jun;73(2):135-7. Int J Lepr Other Mycobact Dis. 2005. PMID: 16830659 No abstract available.

4

Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.

Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, Zeitz M, Kaufmann SH, Schmidt-Ullrich R, Steinhoff U. Visekruna A, et al. J Clin Invest. 2006 Dec;116(12):3195-203. doi: 10.1172/JCI28804. Epub 2006 Nov 22. J Clin Invest. 2006. PMID: 17124531 Free PMC article.

5

Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients.

Visekruna A, Joeris T, Schmidt N, Lawrenz M, Ritz JP, Buhr HJ, Steinhoff U. Visekruna A, et al. Inflamm Bowel Dis. 2009 Apr;15(4):526-33. doi: 10.1002/ibd.20805. Inflamm Bowel Dis. 2009. PMID: 19067411

6

Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.

Visekruna A, Slavova N, Dullat S, Gröne J, Kroesen AJ, Ritz JP, Buhr HJ, Steinhoff U. Visekruna A, et al. Int J Colorectal Dis. 2009 Oct;24(10):1133-9. doi: 10.1007/s00384-009-0679-1. Epub 2009 Mar 10. Int J Colorectal Dis. 2009. PMID: 19274467 Free PMC article.

7

Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma.

Lauscher JC, Gröne J, Dullat S, Hotz B, Ritz JP, Steinhoff U, Buhr HJ, Visekruna A. Lauscher JC, et al. Among authors: visekruna a. Mol Carcinog. 2010 Feb;49(2):121-9. doi: 10.1002/mc.20606. Mol Carcinog. 2010. PMID: 20027638

8

c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.

Visekruna A, Huber M, Hellhund A, Bothur E, Reinhard K, Bollig N, Schmidt N, Joeris T, Lohoff M, Steinhoff U. Visekruna A, et al. Eur J Immunol. 2010 Mar;40(3):671-6. doi: 10.1002/eji.200940260. Eur J Immunol. 2010. PMID: 20049877 Free article.

9

Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.

Schmidt N, Gonzalez E, Visekruna A, Kühl AA, Loddenkemper C, Mollenkopf H, Kaufmann SH, Steinhoff U, Joeris T. Schmidt N, et al. Among authors: visekruna a. Gut. 2010 Jul;59(7):896-906. doi: 10.1136/gut.2009.203554. Gut. 2010. PMID: 20581238

10

c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.

Reinhard K, Huber M, Wostl C, Hellhund A, Toboldt A, Abass E, Casper B, Joeris T, Herr C, Bals R, Steinhoff U, Lohoff M, Visekruna A. Reinhard K, et al. Among authors: visekruna a. Eur J Immunol. 2011 May;41(5):1388-98. doi: 10.1002/eji.201041056. Epub 2011 Apr 11. Eur J Immunol. 2011. PMID: 21469108 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters